title: OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.
authors.affiliation: Department of Surgery, University of Chicago, IL 60637.
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: J C
authors.initials: JC
authors.lastname: Emond
authors.forename: P F
authors.initials: PF
authors.lastname: Whitington
authors.forename: D D
authors.initials: DD
authors.lastname: Black
authors.forename: P P
authors.initials: PP
authors.lastname: Aran
authors.forename: A L
authors.initials: AL
authors.lastname: Baker
authors.forename: F P
authors.initials: FP
authors.lastname: Stuart
authors.forename: C E
authors.initials: CE
authors.lastname: Broelsch
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016031:Liver Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3; D008775:Methylprednisolone